Biovail Settles Ongoing Patent Litigation Over Wellbutrin XL With Generic Firms
Generic drug makers will continue to market the 300 mg dose of the GlaxoSmithKline antidepressant, but the 150 mg strength will not go generic until 2008.
Generic drug makers will continue to market the 300 mg dose of the GlaxoSmithKline antidepressant, but the 150 mg strength will not go generic until 2008.